Literature DB >> 7072685

The association of remote Streptococcus bovis bacteremia with colonic neoplasia.

I A Friedrich, G P Wormser, E B Gottfried.   

Abstract

We prospectively studied five patients with a remote history of Streptococcus bovis bacteremia who had not previously been evaluated for colonic pathology. This study was prompted by several reports of concomitant neoplasia in patients with recent S. bovis bacteremia. The patients were studied at a mean of 32 months after bacteremia. Despite the absence of other signs or symptoms suggestive of bowel disease, a negative test for occult blood in stool and a negative fecal culture for S. bovis, two patients were found to have neoplastic polyps of the colon. These findings suggest that the risk of colonic neoplasia in patients with remote S. bovis septicemia is similar to that found in patients with recent bacteremia, but evaluation of a larger group of these patients will be necessary to establish this risk.

Entities:  

Mesh:

Year:  1982        PMID: 7072685

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Rapid identification of Streptococcus bovis by using combination constitutive enzyme substrate hydrolyses.

Authors:  K J Panosian; S C Edberg
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

2.  Rutin-induced beta-glucosidase activity in Streptococcus faecium VGH-1 and Streptococcus sp. strain FRP-17 isolated from human feces: formation of the mutagen, quercetin, from rutin.

Authors:  I A MacDonald; R G Bussard; D M Hutchison; L V Holdeman
Journal:  Appl Environ Microbiol       Date:  1984-02       Impact factor: 4.792

Review 3.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

4.  Streptococcus bovis endocarditis as a presenting manifestation of idiopathic ulcerative colitis.

Authors:  M Moshkowitz; N Arber; R Wajsman; M Baratz; T Gilat
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.